The Impact of Left Ventricle Ejection Fraction Reduction and Transient Ischemic Dilation in Patients With Normal

Paulo Medeiros1, Bárbara Pereira2, Jorge Rodrigues3

  • 1Cardiology, Hospital de Braga, Braga, PRT.

Cureus
|January 30, 2023
PubMed

Insights

Patients with normal single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) but with reduced left ventricle ejection fraction (LVEF) or increased left ventricle volumes indicating transient ischemic dilatation (TID) have a higher incidence of significant coronary artery disease (CAD). These non-perfusion markers identify high-risk individuals.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Diagnostic Medicine

Background:

  • Coronary artery disease (CAD) is a major cause of mortality in developed nations.
  • Non-invasive functional imaging, like single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI), is recommended for patients with intermediate-to-high pretest probability of CAD.
  • Beyond perfusion, non-perfusion predictors like transient ischemic dilatation (TID) and reduced left ventricle ejection fraction (LVEF) are debated in CAD assessment.

Purpose of the Study:

  • To evaluate the incidence of significant CAD in patients exhibiting non-perfusion high-risk markers despite a normal SPECT-MPI.
  • To investigate the prognostic value of LVEF reduction and TID on SPECT-MPI in identifying significant CAD.

Main Methods:

  • A retrospective, observational, longitudinal study of 197 patients with normal SPECT-MPI.
  • Inclusion criteria included age ≥18 years and availability of gated SPECT for LVEF and volume analysis.
  • Non-perfusion high-risk markers included LVEF reduction ≥5% and TID (stress/rest left ventricle volume ratio ≥ 1.15). The primary endpoint was significant CAD on invasive coronary angiography.

Main Results:

  • 26% of patients showed LVEF reduction ≥5%, and 24.9% had a stress/rest end-systolic volume ratio ≥ 1.15.
  • Patients with LVEF reduction ≥5% and those with a stress/rest end-systolic volume ratio ≥ 1.15 had a significantly shorter time to the primary endpoint (significant CAD).
  • These findings suggest these non-perfusion markers are associated with adverse outcomes.

Conclusions:

  • In patients with normal SPECT-MPI perfusion, LVEF reduction ≥5% and a stress/rest end-systolic volume ratio ≥ 1.15 are associated with a significantly higher incidence of significant CAD.
  • These non-perfusion markers can identify high-risk individuals even with normal myocardial perfusion on SPECT-MPI.
  • The study highlights the importance of considering non-perfusion parameters in the comprehensive assessment of CAD risk.
Abstract